SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-016942
Filing Date
2017-08-09
Accepted
2017-08-09 16:06:18
Documents
55
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pbyi-10q_20170630.htm 10-Q 1764418
2 EX-10.3 pbyi-ex103_133.htm EX-10.3 25260
3 EX-31.1 pbyi-ex311_6.htm EX-31.1 11923
4 EX-31.2 pbyi-ex312_8.htm EX-31.2 11939
5 EX-32.1 pbyi-ex321_9.htm EX-32.1 8884
6 EX-32.2 pbyi-ex322_7.htm EX-32.2 9021
  Complete submission text file 0001564590-17-016942.txt   5998430

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT pbyi-20170630.xml EX-101.INS 1414615
8 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20170630.xsd EX-101.SCH 34072
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbyi-20170630_cal.xml EX-101.CAL 35304
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20170630_def.xml EX-101.DEF 93932
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20170630_lab.xml EX-101.LAB 298530
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20170630_pre.xml EX-101.PRE 220609
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35703 | Film No.: 171017888
SIC: 2834 Pharmaceutical Preparations